THE PROGNOSTIC VALUE OF A NOVEL QUANTITATIVE MGMT PROMOTER METHYLATION SCORE FOR PATIENTS WITH GLIOBLASTOMA

被引：0
|
作者：
Han, S. [1 ]
Ravi, A. [1 ]
Molinaro, A. [1 ]
Clarke, J. L. [1 ]
Oberheim-Bush, N. [1 ]
Chang, S. [1 ]
Berger, M. S. [1 ]
Chehab, F. [1 ]
Butowski, N. A. [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
NEURO-ONCOLOGY | 2017年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P03.07
引用
收藏
页码：34 / 34
页数：1
相关论文
共 50 条
  • [21] PROGNOSTIC AND PREDICTIVE SIGNIFICANCE Of MGMT PROMOTER METHYLATION AND PROTEIN EXPRESSION IN GLIOBLASTOMA PATIENTS
    Spiegl-Kreinecker, S.
    Pirker, C.
    Filipits, M.
    Loetsch, D.
    Buchroithner, J.
    Pichler, J.
    Silye, R.
    Micksche, M.
    Fischer, J.
    Berger, W.
    [J]. NEURO-ONCOLOGY, 2008, 10 (06) : 1080 - 1080
  • [22] MGMT promoter methylation in glioblastoma
    Santosh, Vani
    Sravya, P.
    [J]. NEUROLOGY INDIA, 2018, 66 (04) : 1115 - 1116
  • [23] PROGNOSTIC VALUE OF EGFRVIII EXPRESSION AND ITS CORRELATION WITH MGMT PROMOTER METHYLATION STATUS AND PTEN EXPRESSION IN GLIOBLASTOMA PATIENTS
    Montano, Nicola
    Cenci, Tonia
    Martini, Maurizio
    D'Alessandris, Quintino G.
    Banna, Giuseppe L.
    Maira, Giulio
    De Maria, Ruggero
    Larocca, Luigi M.
    Pallini, Roberto
    [J]. NEURO-ONCOLOGY, 2010, 12 : 38 - 39
  • [24] QUANTITATIVE ANALYSIS OF MGMT PROMOTER METHYLATION AND ITS PROGNOSTIC VALUE IN GLIOBLASTOMA MULTIFORME (GBM) PATIENTS TREATED WITH ALKYLATING CHEMOTHERAPY-PRELIMINARY REPORT
    Bajwa, Samarjeet
    Flanagan, Lisa
    Hernandez, Stephania
    Fu, Dan Beverly
    Bota, Daniela
    Kong, Xiao-Tang
    [J]. NEURO-ONCOLOGY, 2018, 20 : 159 - 159
  • [25] Prognostic value of MGMT promoter status and EGFRvIII expression in glioblastoma patients.
    Montano, N.
    Banna, G. L.
    Martini, M.
    D'Alessandris, G.
    Cenci, T.
    Giuffrida, D.
    Maira, G.
    De Maria, R.
    Larocca, L.
    Paliini, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [26] Prognostic Role of Methylation Status of the MGMT Promoter Determined Quantitatively by Pyrosequencing in Glioblastoma Patients
    Kim, Dae Cheol
    Kim, Ki Uk
    Kim, Young Zoon
    [J]. JOURNAL OF KOREAN NEUROSURGICAL SOCIETY, 2016, 59 (01) : 26 - 36
  • [27] First steps in the definition of a prognostic score based on MGMT methylation status in patients with glioblastoma
    De Carlo, E.
    Gurrieri, L.
    De Maglio, G.
    Gerratana, L.
    Buoro, V.
    Rizzato, S.
    Isola, M.
    Skrap, M.
    Fasola, G.
    Puglisi, F.
    Pizzolitto, S.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [28] Prognostic value of MGMT promoter methylation in glioblastoma patients treated with temozolomide-based chemoradiation: A Portuguese multicentre study
    Costa, Bruno M.
    Caeiro, Claudia
    Gumaraes, Ines
    Martinho, Olga
    Jaraquemada, Teresa
    Augusto, Isabel
    Castro, Ligia
    Osorio, Ligia
    Linhares, Paulo
    Honavar, Mrinalini
    Resende, Mario
    Braga, Fatima
    Silva, Ana
    Pardal, Fernando
    Amorim, Julia
    Nabico, Rui
    Almeida, Rui
    Alegria, Carlos
    Pires, Manuel
    Pinheiro, Celia
    Carvalho, Ernesto
    Lopes, Jose M.
    Costa, Paulo
    Damasceno, Margarida
    Reis, Rui M.
    [J]. ONCOLOGY REPORTS, 2010, 23 (06) : 1655 - 1662
  • [29] MGMT Protein Expression Adds Prognostic Value Beyond MGMT Promoter Methylation and Stratifies Survival Prognoses of Un-Methylated Glioblastoma Patients
    Becker, A.
    Bell, E. H.
    McElroy, J.
    Cui, T.
    Geurts, M.
    Liu, Z.
    Haque, S. J.
    Robe, P.
    Chakravarti, A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S47 - S47
  • [30] Prognostic Impact of the Combination of MGMT Methylation and TERT Promoter Mutation in Glioblastoma
    Tunthanathip, Thara
    Sangkhathat, Surasak
    Tanvejsilp, Pimwara
    Kanjanapradit, Kanet
    [J]. JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE, 2021, 12 (04) : 694 - 703
12345